Free Trial

Prelude Therapeutics (PRLD) News Today

Prelude Therapeutics logo
$0.81 -0.07 (-8.16%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$0.81 0.00 (-0.45%)
As of 07/11/2025 05:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PRLD Latest News

Prelude Therapeutics Founder Acquires 28% More Stock
Prelude Therapeutics CEO buys $467K in common stock
Prelude Therapeutics stock surges on insider buying
Barclays Sticks to Their Sell Rating for Prelude Therapeutics (PRLD)
Prelude Therapeutics reports FY24 EPS ($1.68), consensus ($1.77)
Prelude Therapeutics sees cash runway into 2Q26
Krishna Vaddi Bought 4.9% More Shares In Prelude Therapeutics
Prelude Therapeutics (PRLD) Gets a Sell from Morgan Stanley
Prelude Therapeutics presents first interim data from trial of PRT2527
Prelude Therapeutics price target lowered to $4 from $7 at JMP Securities
Prelude Therapeutics (PRLD) Receives a Sell from Barclays
Get Prelude Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRLD and its competitors with MarketBeat's FREE daily newsletter.

PRLD Media Mentions By Week

PRLD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PRLD
News Sentiment

1.89

0.99

Average
Medical
News Sentiment

PRLD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PRLD Articles
This Week

1

1

PRLD Articles
Average Week

Get Prelude Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRLD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:PRLD) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners